Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state

The cellular origin, clinical significance, and metabolic features of the senescence-associated secretory phenotype (SASP) in prostate cancer remain poorly resolved. We integrated bulk transcriptomes from TCGA-PRAD (primary, n = 495) and SU2C (mCRPC, n = 208), two single-cell RNA-sequencing datasets, seven Visium sections, and one Xenium prostate adenocarcinoma section, together with immunoblotting in LNCaP and castration-adapted C4-2 cells treated with charcoal-stripped serum (CSS), enzalutamide (ENZ), and dihydrotestosterone (DHT). SASP formed a smooth, continuous gradient across bulk tumors rather than discrete subtypes. In Xenium, 4,657 of 25,517 tumor cells (18.3%) were positive for a senescence surrogate driven predominantly by p21 (CDKN1A) transcript detection; the local fraction of these cells correlated with a bin-level matrix-remodeling SASP program and glycolysis, but not with inflammatory SASP. The single-cell atlas revealed expansion of AR-low, stasis/senescence-like states in advanced disease. Within the adenocarcinoma compartment of one CRPC section, senescence-like hotspots showed higher glycolysis scores without a concomitant rise in proliferation. In vitro, CSS and ENZ increased p21/p16 and glycolytic proteins (GLUT1, LDHA, HK2), and treatment with 2-deoxy-D-glucose (2-DG) or the LDHA inhibitor FX-11 was associated with lower p21/p16 abundance. Androgen deprivation is associated with a prostate cancer senescence-like state and a glycolysis-related program; LDHA is a candidate metabolic node for further investigation; the present data do not establish therapeutic selectivity or efficacy. These spatial associations do not establish the cellular source of the SASP-related transcripts or paracrine signaling.

Authors

Institutions

Publication Details

Journal
Translational Oncology
Published
2026-11-18
DOI
https://doi.org/10.1016/j.tranon.2026.103120
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state

Can Wei, Jianye Yang, Jing Xu, Rongrong Li et al.
Translational Oncology
Prostate Cancer Treatment and Research
article

Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state

Can Wei, Jianye Yang, Jing Xu, Rongrong Li, Gege Yuan, Yanbin Zhang
article en

Abstract

The cellular origin, clinical significance, and metabolic features of the senescence-associated secretory phenotype (SASP) in prostate cancer remain poorly resolved. We integrated bulk transcriptomes from TCGA-PRAD (primary, n = 495) and SU2C (mCRPC, n = 208), two single-cell RNA-sequencing datasets, seven Visium sections, and one Xenium prostate adenocarcinoma section, together with immunoblotting in LNCaP and castration-adapted C4-2 cells treated with charcoal-stripped serum (CSS), enzalutamide (ENZ), and dihydrotestosterone (DHT). SASP formed a smooth, continuous gradient across bulk tumors rather than discrete subtypes. In Xenium, 4,657 of 25,517 tumor cells (18.3%) were positive for a senescence surrogate driven predominantly by p21 (CDKN1A) transcript detection; the local fraction of these cells correlated with a bin-level matrix-remodeling SASP program and glycolysis, but not with inflammatory SASP. The single-cell atlas revealed expansion of AR-low, stasis/senescence-like states in advanced disease. Within the adenocarcinoma compartment of one CRPC section, senescence-like hotspots showed higher glycolysis scores without a concomitant rise in proliferation. In vitro, CSS and ENZ increased p21/p16 and glycolytic proteins (GLUT1, LDHA, HK2), and treatment with 2-deoxy-D-glucose (2-DG) or the LDHA inhibitor FX-11 was associated with lower p21/p16 abundance. Androgen deprivation is associated with a prostate cancer senescence-like state and a glycolysis-related program; LDHA is a candidate metabolic node for further investigation; the present data do not establish therapeutic selectivity or efficacy. These spatial associations do not establish the cellular source of the SASP-related transcripts or paracrine signaling.

Translational OncologyVol. 75
Shanghai Medical College of Fudan University (CN), Anhui Medical University (CN), Fudan University (CN), Nanjing Children's Hospital (CN), Fudan University Shanghai Cancer Center (CN), First Affiliated Hospital of Anhui Medical University (CN), Second Affiliated Hospital of Nanjing Medical University (CN), Second Affiliated Hospital of Anhui Medical University (CN), Third People's Hospital of Hefei (CN), Nanjing Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon